Cargando…

“Weakly Ligated, Labile Ligand” Nanoparticles: The Case of Ir(0)(n)·(H(+)Cl(–))(m)

[Image: see text] It is of considerable interest to prepare weakly ligated, labile ligand (WLLL) nanoparticles for applications in areas such as chemical catalysis. WLLL nanoparticles can be defined as nanoparticles with sufficient, albeit minimal, surface ligands of moderate binding strength to met...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondloch, Joseph E., Özkar, Saim, Finke, Richard G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643726/
https://www.ncbi.nlm.nih.gov/pubmed/31458138
http://dx.doi.org/10.1021/acsomega.8b01569
_version_ 1783437155953016832
author Mondloch, Joseph E.
Özkar, Saim
Finke, Richard G.
author_facet Mondloch, Joseph E.
Özkar, Saim
Finke, Richard G.
author_sort Mondloch, Joseph E.
collection PubMed
description [Image: see text] It is of considerable interest to prepare weakly ligated, labile ligand (WLLL) nanoparticles for applications in areas such as chemical catalysis. WLLL nanoparticles can be defined as nanoparticles with sufficient, albeit minimal, surface ligands of moderate binding strength to meta-stabilize nanoparticles, initial stabilizer ligands that can be readily replaced by other, desired, more strongly coordinating ligands and removed completely when desired. Herein, we describe WLLL nanoparticles prepared from [Ir(1,5-COD)Cl](2) reduction under H(2), in acetone. The results suggest that H(+)Cl(–)-stabilized Ir(0)(n) nanoparticles, herein Ir(0)(n)·(H(+)Cl(–))(a), serve as a WLLL nanoparticle for the preparation of, as illustrative examples, five specific nanoparticle products: Ir(0)(n)·(Cl(–)Bu(3)NH(+))(a), Ir(0)(n)·(Cl(–)Dodec(3)NH(+))(a), Ir(0)(n)·(POct(3))(0.2n)(Cl(–)H(+))(b), Ir(0)(n)·(POct(3))(0.2n), and the γ-Al(2)O(3)-supported heterogeneous catalyst, Ir(0)(n)·(γ-Al(2)O(3))(a)(Cl(–)H(+))(b). (where a and b vary for the differently ligated nanoparticles; in addition, solvent can be present as a nanoparticle surface ligand). With added POct(3) as a key, prototype example, an important feature is that a minimum, desired, experimentally determinable amount of ligand (e.g., just 0.2 equiv POct(3) per mole of Ir) can be added, which is shown to provide sufficient stabilization that the resultant Ir(0)(n)·(POct(3))(0.2n)(Cl(–)H(+))(b) is isolable. Additionally, the initial labile ligand stabilizer HCl can be removed to yield Ir(0)(n)·(POct(3))(0.2n) that is >99% free of Cl(–) by a AgCl precipitation test. The results provide strong support for the weakly ligated, labile ligand nanoparticle concept and specific support for Ir(0)(n)·(H(+)Cl(–))(a) as a WLLL nanoparticle.
format Online
Article
Text
id pubmed-6643726
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-66437262019-08-27 “Weakly Ligated, Labile Ligand” Nanoparticles: The Case of Ir(0)(n)·(H(+)Cl(–))(m) Mondloch, Joseph E. Özkar, Saim Finke, Richard G. ACS Omega [Image: see text] It is of considerable interest to prepare weakly ligated, labile ligand (WLLL) nanoparticles for applications in areas such as chemical catalysis. WLLL nanoparticles can be defined as nanoparticles with sufficient, albeit minimal, surface ligands of moderate binding strength to meta-stabilize nanoparticles, initial stabilizer ligands that can be readily replaced by other, desired, more strongly coordinating ligands and removed completely when desired. Herein, we describe WLLL nanoparticles prepared from [Ir(1,5-COD)Cl](2) reduction under H(2), in acetone. The results suggest that H(+)Cl(–)-stabilized Ir(0)(n) nanoparticles, herein Ir(0)(n)·(H(+)Cl(–))(a), serve as a WLLL nanoparticle for the preparation of, as illustrative examples, five specific nanoparticle products: Ir(0)(n)·(Cl(–)Bu(3)NH(+))(a), Ir(0)(n)·(Cl(–)Dodec(3)NH(+))(a), Ir(0)(n)·(POct(3))(0.2n)(Cl(–)H(+))(b), Ir(0)(n)·(POct(3))(0.2n), and the γ-Al(2)O(3)-supported heterogeneous catalyst, Ir(0)(n)·(γ-Al(2)O(3))(a)(Cl(–)H(+))(b). (where a and b vary for the differently ligated nanoparticles; in addition, solvent can be present as a nanoparticle surface ligand). With added POct(3) as a key, prototype example, an important feature is that a minimum, desired, experimentally determinable amount of ligand (e.g., just 0.2 equiv POct(3) per mole of Ir) can be added, which is shown to provide sufficient stabilization that the resultant Ir(0)(n)·(POct(3))(0.2n)(Cl(–)H(+))(b) is isolable. Additionally, the initial labile ligand stabilizer HCl can be removed to yield Ir(0)(n)·(POct(3))(0.2n) that is >99% free of Cl(–) by a AgCl precipitation test. The results provide strong support for the weakly ligated, labile ligand nanoparticle concept and specific support for Ir(0)(n)·(H(+)Cl(–))(a) as a WLLL nanoparticle. American Chemical Society 2018-11-01 /pmc/articles/PMC6643726/ /pubmed/31458138 http://dx.doi.org/10.1021/acsomega.8b01569 Text en Copyright © 2018 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Mondloch, Joseph E.
Özkar, Saim
Finke, Richard G.
“Weakly Ligated, Labile Ligand” Nanoparticles: The Case of Ir(0)(n)·(H(+)Cl(–))(m)
title “Weakly Ligated, Labile Ligand” Nanoparticles: The Case of Ir(0)(n)·(H(+)Cl(–))(m)
title_full “Weakly Ligated, Labile Ligand” Nanoparticles: The Case of Ir(0)(n)·(H(+)Cl(–))(m)
title_fullStr “Weakly Ligated, Labile Ligand” Nanoparticles: The Case of Ir(0)(n)·(H(+)Cl(–))(m)
title_full_unstemmed “Weakly Ligated, Labile Ligand” Nanoparticles: The Case of Ir(0)(n)·(H(+)Cl(–))(m)
title_short “Weakly Ligated, Labile Ligand” Nanoparticles: The Case of Ir(0)(n)·(H(+)Cl(–))(m)
title_sort “weakly ligated, labile ligand” nanoparticles: the case of ir(0)(n)·(h(+)cl(–))(m)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643726/
https://www.ncbi.nlm.nih.gov/pubmed/31458138
http://dx.doi.org/10.1021/acsomega.8b01569
work_keys_str_mv AT mondlochjosephe weaklyligatedlabileligandnanoparticlesthecaseofir0nhclm
AT ozkarsaim weaklyligatedlabileligandnanoparticlesthecaseofir0nhclm
AT finkerichardg weaklyligatedlabileligandnanoparticlesthecaseofir0nhclm